In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dassault Systemes BIOVIA Corp

Latest From Dassault Systemes BIOVIA Corp

Asia On The Move: Pfizer Asia Clinical Head Joins APCER

July saw Pfizer’s Asia clinical development head depart and Merck Serono pick a young Taiwanese executive as its president for Japan. Personnel changes also took place at Mitsubishi Tanabe and Zeria Pharma in Japan, and at Servier in China.

BioPharmaceutical China

Optibrium Ltd.

Drug development is difficult and risky, and the timescales are long. Optibrium Ltd. has developed StarDrop, a software platform designed to support drug discovery by guiding decisions in the design and selection of potential drug candidates based on complex and uncertain data. Through chemical space visualization, supported by a visualization tool and probabilistic scoring, StarDrop compares candidate molecules against a weighted profile of required properties, and helps users to identify chemistries with a high chance of success in order to better focus their expensive in-house resources.


Curis Reformed: Unearthing Preclinical Value

From its start as a promising powerhouse in the emerging area of regenerative medicine and through product failures, valuation crunches and capital constraints, Curis has in the past two years embraced an almost old-school approach to the biotechnology business. Bereft now of the late-stage assets (and corresponding cash burn) that helped drive its formation through merger in 2000, the company has leveraged its preclinical expertise in cell signaling to sign broad, value-creating alliances with top-shelf biotechnology and pharmaceutical partners.

BioPharmaceutical Strategy

QuantumBio Inc.

By combining quantum chemistry and computing power, QuantumBio Inc. says it can model large macromolecules far better and more efficiently than currently available mechanics-based software. The company's tools promise better predictability of chemical and physical properties for virtual screening, QSAR, ADME/Tox, lead optimization and docking.

BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools